Skip to content
Peoria Joint Material
Cartilage biology · evidence · local access

Peoria Joint Material

Questions about joint soreness and regenerative medicine

What to do before using these answers

Morning stiffness that eases with movement is different from sudden, severe soreness. Fever, swelling, new weakness, or a bad fall may need urgent care.

These short answers cover the questions people often bring to a joint visit. They can't take the place of an exam.

What is cartilage in my knee?

Cartilage is the smooth layer covering the bone ends inside your knee. It doesn't readily replace a broad worn area, but stronger muscles may make movement easier.

What helps a stiff joint loosen?

Gentle motion and warmth before activity may help morning stiffness. If the joint stays swollen, catches, or hurts more each day, don't answer it with harder exercise.

Can worn cartilage be repaired?

A small hole in knee cartilage may sometimes be repaired with an operation. Widespread wear is different, and office care can't promise to rebuild the whole smooth layer.

How can I support my joints naturally?

Regular strength work, gradual activity, and weight control when it applies may help. You'll need an amount that fits your joint, health, and usual day.

Will an X-ray or scan show whether care worked?

An X-ray or scan can show bone and the joint surface. It can't fully show whether you sleep better, walk farther, or feel less sore.

How much does regenerative medicine cost in Arizona?

Here, regenerative medicine means office care made from body material and placed in a sore joint; the price depends on the treatment and visit count. This guide doesn't list a Peoria price, so ask the clinic for a written total before agreeing; insurance may not pay.

Sources

  1. A concise review of mesenchymal stem cells for functional cartilage tissue engineering sets out the underlying problem: articular cartilage is avascular and has very limited intrinsic repair capacity, which is precisely why engineered and cell-based approaches are being pursued - and why building tissue that matches native articular cartilage in composition and mechanical function remains an unsolved engineering problem rather than a delivered clinical product.

    Tan AR, et al. — Concise Review: Mesenchymal Stem Cells for Functional Cartilage Tissue Engineering: Taking Cues from Chondrocyte-Based Constructs.. Stem cells translational medicine, 2017. DOI: 10.1002/sctm.16-0271.

  2. The SUMMIT randomized trial treated 144 patients (mean age 33.8, mean lesion 4.8 cm2) with at least one symptomatic focal cartilage defect (Outerbridge III/IV, >=3 cm2) of the femoral condyle or trochlea. Matrix-applied characterized autologous cultured chondrocytes (MACI) improved KOOS pain (37.0 to 82.5) and function significantly more than microfracture (pain 35.5 to 70.9) at 2 years, with histological and MRI assessment of the repair tissue. This is what a positive cartilage-repair trial looks like - in young patients with a discrete hole, not a worn joint.

    Saris D, et al. — Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial.. The American journal of sports medicine, 2014. DOI: 10.1177/0363546514528093.

  3. MACI (autologous cultured chondrocytes on a porcine collagen membrane, Vericel; STN BL 125603) IS an FDA-LICENSED cell therapy - and its approved indication is narrow and specific: repair of symptomatic, single or multiple FULL-THICKNESS cartilage defects OF THE KNEE, with or without bone involvement, in adults. It is not approved for osteoarthritis. The existence of one licensed cartilage cell therapy for focal defects is the sharpest available way to show what a licensed 'regeneration' product actually looks like, and how far it is from an injection for a worn joint.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — MACI (autologous cultured chondrocytes on porcine collagen membrane). FDA, 2024.

  4. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

    US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

  5. FORWARD, the longest disease-modifying osteoarthritis drug trial reported to date, gave intra-articular sprifermin (a recombinant FGF-18) or placebo to knee OA patients and followed 378 of them for 5 years. Sprifermin produced a significant, sustained dose-response INCREASE in total femorotibial cartilage thickness versus placebo - and WOMAC pain improved about 50% from baseline in ALL groups, including placebo. It is the cleanest demonstration in the literature that adding measurable cartilage and relieving pain are two different results, and that one does not deliver the other.

    Eckstein F, et al. — Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study.. Annals of the rheumatic diseases, 2021. DOI: 10.1136/annrheumdis-2020-219181.

What to ask about your sore joint

Take your questions, health history, and earlier X-rays or scans. You'll want clear answers about the exam, likely relief, cost, and follow-up.

Talk to the clinic team